Starr Technology Commercialization Fund

Available to investigators with a current or previously funded SCC award ONLY


The Starr Technology Commercialization Fund (Starr TCF) is an initiative by the Starr Cancer Consortium (SCC) funded by the Starr Foundation. The purpose of the Starr TCF is to provide the requisite support to collaborative projects previously funded by the SCC so that Intellectual Property (IP) from that project can reach a commercialization endpoint.

The Starr TCF Request for Proposal (RFP) solicits proposals for commercial development of IP from projects previously funded by the SCC.

Eligibility Criteria

Projects that are appropriate for Starr TCF funding are those that meet the following criteria:

1. Previously-funded by the Starr Cancer Consortium and IP has been generated or improved;

2. Such IP is owned by one or more of the SCC member institutions that participated in the
previously-funded collaborative project and steps have been taken to protect it;

3. The IP is at a later stage in the development cycle such that rate limiting steps to reach a
commercialization endpoint may, but need not include some or all of the following:
international patent applications, laboratory and animal studies enabling an Investigational
New Drug Application with US Food and Drug Administration; drug manufacturing,
including scale-up and formulation and license fees for acquiring enabling technology rights for manufacturing; Phase 1 clinical trial; a business plan; and/or initial financing, if a new company is the appropriate commercialization endpoint.

2nd Starr Technology Commercialization Fund competition

Key Dates

RFP Issue date: October 18, 2018
Letter of Intent deadline: November 29, 2018
Invitation to submit an application:
January 17, 2019
Application deadline:
February 28, 2019
Expected award start date: August 1, 2019

Application Process

Applicants invited to submit an application must use the Starr TCF Application Template

Completed applications must be uploaded via the Application Submission Page.

The deadline for application submission is February 28, 2019 at 5:00PM


1st Starr Technology Commercialization Fund competition

In the 1st Starr TCF competition, 6 Letters of Intent were received; 4 applications were invited; 1 award was made.


For further information contact:

Sylvie Le Blancq, Ph.D.
Executive Director
Starr Cancer Consortium
Tel: 646 888 3773